Association of blood lactate with carotid atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study

Atherosclerosis

Volumn 228, Issue 1, 2013, Pages 249-255

  Shantha, Ghanshyam Palamaner Subash ^a   Wasserman, Bruce ^b   Astor, Brad C ^a,b   Coresh, Josef ^a,b   Brancati, Fredrick ^a,b   Sharrett, A Richey ^a   Young, J Hunter ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Carotid arteries; Epidemiology; Lactate; Plaque

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; C REACTIVE PROTEIN; CHOLESTEROL; GADOLINIUM; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LACTIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AFRICAN AMERICAN; AGE; AGED; ARTERIAL WALL THICKNESS; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CORRELATIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG USE; ETHNICITY; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; CHOLESTEROL, HDL; FEMALE; GADOLINIUM; HUMANS; INSULIN RESISTANCE; LACTIC ACID; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; RESIDENCE CHARACTERISTICS; RISK FACTORS; TRIGLYCERIDES;

EID: 84876807578     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.02.014     Document Type: Article

References (38)

1. Madamanchi N.R., Runge M.S. Mitochondrial dysfunction in atherosclerosis. Circ Res 2007, 100(4):460-473.
2. Robinson B.H. Lactic acidemia and mitochondrial disease. Mol Genet Metab 2006, 89(1-2):3-13.
3. Gerbitz K.D., Gempel K., Brdiczka D. Mitochondria and diabetes-genetic, biochemical, and clinical implications of the cellular energy circuit. Diabetes 1996, 45:113-126.
4. Simoneau J.A., Colberg S.R., Thaete F.L., Kelley D.E. Skeletal muscle glycolytic and oxidative enzyme capacities are determinants of insulin sensitivity and muscle composition in obese women. FASEB J 1995, 9:273-278.
5. Puddu P., Puddu G.M., Cravero E., De Pascalis S., Muscari A. The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis. J Biomed Sci 2009, 16:112.
6. Tanaka H., Seals D.R. Endurance exercise performance in masters athletes: age-associated changes and underlying physiological mechanisms. J Physiol 2008, 586(1):55-63.
7. Jansen T.C., van Bommel J., Bakker J. Blood lactate monitoring in critically ill patients: a systematic health technology assessment. Crit Care Med 2009, 37(10):2827-2839.
8. Avogaro A., Toffolo G., Miola M., et al. Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals. J Clin Invest 1996, 98(1):108-115.
9. Sandqvist M.M., Eriksson J.W., Jansson P.A. Increased lactate release per fat cell in normoglycemic first-degree relatives of individuals with type 2 diabetes. Diabetes 2001, 50(10):2344-2348.
10. Hosogai N., Fukuhara A., Oshima K., et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007, 56:901-911.
11. Crawford S.O., Hoogeveen R.C., Brancati F.L., et al. Association of blood lactate with type 2 diabetes: the Atherosclerosis Risk in Communities Carotid MRI Study. Int J Epidemiol 2010, 39(6):1647-1655.
12. The ARIC investigators The Atherosclerosis Risk in Communities (ARIC) study: design and objectives-the ARIC investigators. Am J Epidemiol 1989, 129(4):687-702.
13. Heiss G., Sharrett A.R., Barnes R., Chambless L.E., Szklo M., Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991, 134(3):250-256.
14. Wasserman B.A., Smith W.I., Trout H.H., Cannon R.O., Balaban R.S., Arai A.E. Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging initial results. Radiology 2002, 223(2):566-573.
15. Wasserman B.A., Astor B.C., Sharrett A.R., Swingen C., Catellier D. MRI measurements of carotid plaque in the atherosclerosis risk in communities (ARIC) study: methods, reliability and descriptive statistics. J Magn Reson Imaging 2010, 31(2):406-415.
16. Virani S.S., Nambi V., Hoogeveen R., et al. Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. Eur Heart J 2011, 32(4):459-468.
17. Davis T.M., Jackson D., Davis W.A., Bruce D.G., Chubb P. The relationship between metformin therapy and the fasting plasma lactate in type 2 diabetes: the Fremantle Diabetes Study. Br J Clin Pharmacol 2001, 52:137-144.
18. Barhan D., Trinder P. An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst 1972, 97:142.
19. ARIC Coordinating Center Atherosclerosis risk in communities study protocol: lipid and lipoprotein determinations, manual 8 1994, ARIC study website, [last accessed 15.06.12]. http://www.cscc.unc.edu/aric/pubuse/manual/Lipid_and_Lipoprotein_Determinations.1_8.pdf.
20. ARIC Coordinating Center Atherosclerosis risk in communities study protocol: clinical chemistry determinations, manual 10 1991, ARIC study website, [last accessed 15.06.12]. http://www.cscc.unc.edu/aric/pubuse/manual/Clinical_Chemistry_Determinations.1_10.pdf.
21. ARIC Coordinating Center Atherosclerosis risk in communities study protocol: cohort component procedures, manual 2 1997, ARIC study website, [last accessed 15.06.12]. http://www.cscc.unc.edu/aric/pubuse/manual/Cohort_Procedures.1_2.pdf.
22. UCLA Academic Technology Services Analyzing data with a stratified sampling design: stata 9 2006, Stata Computing, College Station, Texas.
23. Astor B.C., Sharrett A.R., Coresh J., Chambless L.E., Wasserman B.A. Remodeling of carotid arteries detected with MR imaging: atherosclerosis risk in communities carotid MRI study. Radiology 2010, 256(3):879-886.
24. Wagenknecht L., Wasserman B., Chambless L., et al. Correlates of carotid plaque presence and composition as measured by MRI: the Atherosclerosis Risk in Communities Study. Circ Cardiovasc Imaging 2009, 2(4):314-322.
25. Saba L., Sanfilippo R., Pascalis L., Montisci R., Caddeo G., Mallarini G. Carotid artery wall thickness and ischemic symptoms: evaluation using multi-detector-row CT angiography. Eur Radiol 2008, 18(9):1962-1971.
26. Zureik M., Ducimetiere P., Touboul P.J., et al. Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the aging vascular study (EVA). Aterioscler Thromb Vasc Bio 2000, 20(6):1622-1629.
27. Inoue K., Matsumoto M., Shono T., Toyokawa S., Moriki A. Increased intima-media thickness and atherosclerotic plaque in the carotid artery as risk factors for silent brain infarcts. J Stroke Cerebrovasc Dis 2007, 16:14-20.
28. Pasterkamp G., Schoneveld A.H., van der Wal A.C., et al. Relation of arterial geometry to luminal narrowing and histologic markers for plaque vulnerability: the remodeling paradox. J Am Coll Cardiol 1998, 32:655-662.
29. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 2003, 108:1664-1672.
30. Kelley D.E., Slasky B.S., Janosky J. Skeletal muscle density: effects of obesity and non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1991, 54:509-515.
31. Del P.S., Bonadonna R.C., Bonora E., et al. Characterization of cellular defects of insulin action in type 2 (non- insulin-dependent) diabetes mellitus. J Clin Invest 1993, 91:484-494.
32. Morino K., Petersen K.F., Dufour S., et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest 2005, 115:3587-3593.
33. Kelley D.E., He J., Menshikova E.V., Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002, 51:2944-2950.
34. Patti M.E., Butte A.J., Crunkhorn S., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci USA 2003, 100:8466-8471.
35. Mootha V.K., Lindgren C.M., Eriksson K.F., et al. PGC-1alpharesponsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003, 34:267-273.
36. Petersen K.F., Dufour S., Befroy D., Garcia R., Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004, 350:664-671.
37. Bruce C.R., Anderson M.J., Carey A.L., et al. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endocrinol Metab 2003, 88:5444-5451.
38. Lowell B.B., Shulman G.I. Mitochondrial dysfunction and type 2 diabetes. Science 2005, 307:384-387.